CHAMPIONS ONCOLOGY, INC. Deferred Revenue
CHAMPIONS ONCOLOGY, INC. (CSBR) had Deferred Revenue of $4.02 million as of 2019-04-30, per its 10-K filed 2019-07-29.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueCurrent · last filed 2019-07-29
- 2019-04-30: Deferred Revenue, Current $4.02M.
- 2018-04-30: Deferred Revenue, Current $4.70M.
- 2018-01-31: Deferred Revenue, Current $3.85M.
- 2017-10-31: Deferred Revenue, Current $3.88M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2019-04-30 | $4.02M 10-K · filed 2019-07-29 |
| 2018-04-30 | $4.70M 10-K · filed 2019-07-29 |
| 2018-01-31 | $3.85M 10-Q · filed 2018-03-19 |
| 2017-10-31 | $3.88M 10-Q · filed 2017-12-15 |
| 2017-07-31 | $3.74M 10-Q · filed 2017-09-14 |
| 2017-04-30 | $4.91M 10-K · filed 2018-07-30 |
| 2017-01-31 | $3.62M 10-Q · filed 2017-03-17 |
| 2016-10-31 | $3.14M 10-Q · filed 2016-12-14 |
| 2016-07-31 | $2.70M 10-Q · filed 2016-09-14 |
| 2016-04-30 | $3.14M 10-K · filed 2017-07-28 |
| 2016-01-31 | $2.88M 10-Q · filed 2016-03-16 |
| 2015-10-31 | $1.64M 10-Q · filed 2015-12-15 |
| 2015-07-31 | $1.91M 10-Q · filed 2015-09-11 |
| 2015-04-30 | $2.01M 10-K · filed 2016-07-29 |
| 2015-01-31 | $2.31M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $1.76M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $1.67M 10-Q · filed 2014-09-12 |
| 2014-04-30 | $2.09M 10-K · filed 2015-07-29 |
| 2014-01-31 | $2.10M 10-Q · filed 2014-03-14 |
| 2013-10-31 | $1.96M 10-Q · filed 2013-12-13 |
| 2013-07-31 | $859.00K 10-Q · filed 2013-09-13 |
| 2013-04-30 | $1.11M 10-K · filed 2014-07-28 |
| 2013-01-31 | $1.02M 10-Q · filed 2013-03-13 |
| 2012-10-31 | $1.21M 10-Q · filed 2012-12-13 |
| 2012-07-31 | $918.00K 10-Q · filed 2012-09-12 |
| 2012-04-30 | $1.19M 10-K · filed 2013-07-26 |
| 2012-01-31 | $1.50M 10-Q · filed 2012-03-14 |
| 2011-10-31 | $1.90M 10-Q · filed 2011-12-14 |
| 2011-07-31 | $2.08M 10-Q · filed 2011-09-13 |
| 2011-04-30 | $1.62M 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |